Ignite Creation Date:
2025-12-24 @ 7:36 PM
Ignite Modification Date:
2025-12-25 @ 5:17 PM
Study NCT ID:
NCT01348503
Status:
TERMINATED
Last Update Posted:
2015-08-31
First Post:
2011-05-04
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Lenalidomide in Combination With a Fixed Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma
Sponsor:
Indiana University School of Medicine
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-05
Start Date Type:
None
Primary Completion Date:
2012-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-03
Completion Date Type:
ACTUAL
First Submit Date:
2011-05-04
First Submit QC Date:
None
Study First Post Date:
2011-05-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-08-28
Last Update Post Date:
2015-08-31
Last Update Post Date Type:
ESTIMATED